The Dual Role of NRF2 in Colorectal Cancer: Targeting NRF2 As a Potential Therapeutic Approach

Overview

Journal J Inflamm Res

Publisher Dove Medical Press

Date 2024 Sep 9

PMID 39247839

Authors

Mengyun Hu

Lingling Yuan

Jie Zhu

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC), as the third most common bisexual cancer worldwide, requires urgent research on its underlying mechanisms and intervention methods. NRF2 is an important transcription factor involved in the regulation of redox homeostasis, protein degradation, DNA repair, and other cancer processes, playing an important role in cancer. In recent years, the complex role of NRF2 in CRC has been continuously revealed: on the one hand, it exhibits a chemopreventive effect on cancer by protecting normal cells from oxidative stress, and on the other hand, it also exhibits a protective effect on malignant cells. Therefore, this article explores the dual role of NRF2 and its related signaling pathways in CRC, including their chemical protective properties and promoting effects in the occurrence, development, metastasis, and chemotherapy resistance of CRC. In addition, this article focuses on exploring the regulation of NRF2 in CRC ferroptosis, as well as NRF2 drug modulators (activators and inhibitors) targeting CRC, including natural products, compounds, and traditional Chinese medicine formulations.

Citing Articles

Luteolin induces oxidative stress and apoptosis via dysregulating the cytoprotective Nrf2-Keap1-Cul3 redox signaling in metastatic castration-resistant prostate cancer cells.

Eryilmaz I, Colakoglu Bergel C, Arioz B, Huriyet N, Cecener G, Egeli U Mol Biol Rep. 2024; 52(1):65.

PMID: 39699825 DOI: 10.1007/s11033-024-10178-4.

References

Cernigliaro C, DAnneo A, Carlisi D, Giuliano M, Marino Gammazza A, Barone R . Ethanol-Mediated Stress Promotes Autophagic Survival and Aggressiveness of Colon Cancer Cells via Activation of Nrf2/HO-1 Pathway. Cancers (Basel). 2019; 11(4). PMC: 6521343. DOI: 10.3390/cancers11040505. View

Chen G, Gong T, Wang Z, Wang Z, Lin X, Chen S . Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution. Cell Oncol (Dordr). 2022; 45(6):1155-1167. DOI: 10.1007/s13402-022-00705-5. View

Chang L, Fan C, Tseng W, Hua C . Associations between the Nrf2/Keap1 pathway and mitochondrial functions in colorectal cancer are affected by metastasis. Cancer Biomark. 2019; 27(2):163-171. DOI: 10.3233/CBM-190828. View

Sekar V, Anandasadagopan S, Ganapasam S . Genistein regulates tumor microenvironment and exhibits anticancer effect in dimethyl hydrazine-induced experimental colon carcinogenesis. Biofactors. 2016; 42(6):623-637. DOI: 10.1002/biof.1298. View

Zhou H, Liu Z, Wang Y, Wen X, Amador E, Yuan L . Colorectal liver metastasis: molecular mechanism and interventional therapy. Signal Transduct Target Ther. 2022; 7(1):70. PMC: 8897452. DOI: 10.1038/s41392-022-00922-2. View

Jeong S, Farag A, Yun H, Jeong Y, Kim D, Jo M . AF8c, a Multi-Kinase Inhibitor Induces Apoptosis by Activating DR5/Nrf2 via ROS in Colorectal Cancer Cells. Cancers (Basel). 2022; 14(13). PMC: 9264837. DOI: 10.3390/cancers14133043. View

Zhao Y, Feng X, Chen Y, Selfridge J, Gorityala S, Du Z . 5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against -Mutant Colorectal Cancers. Cancer Res. 2020; 80(21):4815-4827. PMC: 7642187. DOI: 10.1158/0008-5472.CAN-20-0600. View

Yao J, Zhao L, Zhao Q, Zhao Y, Sun Y, Zhang Y . NF-κB and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis. Cell Death Dis. 2014; 5:e1283. PMC: 4611709. DOI: 10.1038/cddis.2014.221. View

Kang K, Piao M, Hyun Y, Zhen A, Cho S, Ahn M . Luteolin promotes apoptotic cell death via upregulation of Nrf2 expression by DNA demethylase and the interaction of Nrf2 with p53 in human colon cancer cells. Exp Mol Med. 2019; 51(4):1-14. PMC: 6465248. DOI: 10.1038/s12276-019-0238-y. View

10.

Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag C, Laversanne M . Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023; 72(2):338-344. DOI: 10.1136/gutjnl-2022-327736. View

11.

Sena P, Mancini S, Benincasa M, Mariani F, Palumbo C, Roncucci L . Metformin Induces Apoptosis and Alters Cellular Responses to Oxidative Stress in Ht29 Colon Cancer Cells: Preliminary Findings. Int J Mol Sci. 2018; 19(5). PMC: 5983851. DOI: 10.3390/ijms19051478. View

12.

Shukla K, Sonowal H, Saxena A, Ramana K, Srivastava S . Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells. Cancer Lett. 2017; 411:57-63. PMC: 5693654. DOI: 10.1016/j.canlet.2017.09.031. View

13.

Zhang C, He L, Ye H, Liu D, Zhu Y, Miao D . Nrf2 is a key factor in the reversal effect of curcumin on multidrug resistance in the HCT‑8/5‑Fu human colorectal cancer cell line. Mol Med Rep. 2018; 18(6):5409-5416. PMC: 6236280. DOI: 10.3892/mmr.2018.9589. View

14.

Shahcheraghi S, Salemi F, Peirovi N, Ayatollahi J, Alam W, Khan H . Nrf2 Regulation by Curcumin: Molecular Aspects for Therapeutic Prospects. Molecules. 2022; 27(1). PMC: 8746993. DOI: 10.3390/molecules27010167. View

15.

Lv Y, Zhang S, Weng X, Huang J, Zhao H, Dai X . Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2/GPX4 pathway. FASEB J. 2023; 37(6):e22992. DOI: 10.1096/fj.202300083R. View

16.

Peng S, Shen L, Yu X, Zhang L, Xu K, Xia Y . The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis. Front Immunol. 2023; 14:1200111. PMC: 10285877. DOI: 10.3389/fimmu.2023.1200111. View

17.

Trivedi P, Jena G, Tikoo K, Kumar V . Melatonin modulated autophagy and Nrf2 signaling pathways in mice with colitis-associated colon carcinogenesis. Mol Carcinog. 2015; 55(3):255-67. DOI: 10.1002/mc.22274. View

18.

Gao L, Yuan F, Che G, Xiao X, Nie X, Wang Y . Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer. J Cell Biochem. 2019; 120(8):12311-12320. DOI: 10.1002/jcb.28495. View

19.

Tang Z, Wang L, Chen Y, Zheng X, Wang R, Liu B . Quercetin reverses 5-fluorouracil resistance in colon cancer cells by modulating the NRF2/HO-1 pathway. Eur J Histochem. 2023; 67(3). PMC: 10476536. DOI: 10.4081/ejh.2023.3719. View

20.

Chen L, Jin X, Luo J, Duan J, Cai M, Chen J . ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma. Oncogene. 2021; 40(40):5925-5937. DOI: 10.1038/s41388-021-01965-5. View